A B C D G G/A Figure 1. Sequencing reveals mosaicism for point mutation. A. Sequencing shows a homozygous c.862 G>A mutation in the DNA from tumor of unilaterally.

Slides:



Advertisements
Similar presentations
Autosomal dominant inheritance Risks to children where both parents are affected: the basics a tutorial to show how the genes segregate to give the typical.
Advertisements

Pedigree analysis through genetic hypothesis testing
Problem 1 James is the only person in his kindred affected by DMD. He has one unaffected brother, Joe. DNA analysis show that James has a deletion in the.
Germline and Somatic Mutations of the STK11/LKB1 Peutz-Jeghers Gene in Pancreatic and Biliary Cancers  Gloria H. Su, Ralph H. Hruban, Ravi K. Bansal,
Epidermolysis Bullosa: Novel and De Novo Premature Termination Codon and Deletion Mutations in the Plectin Gene Predict Late-Onset Muscular Dystrophy 
Patient VB Li-Fraumeni Syndrome.
A Targeted High-Throughput Next-Generation Sequencing Panel for Clinical Screening of Mutations, Gene Amplifications, and Fusions in Solid Tumors  Rajyalakshmi.
Dyschromatosis Symmetrica Hereditaria and Aicardi-Goutières Syndrome 6 Are Phenotypic Variants Caused by ADAR1 Mutations  Michihiro Kono, Fumihiro Matsumoto,
STEVE S. SOMMER, M.D., Ph.D.  Mayo Clinic Proceedings 
Different mode and types of inheritance
DNA-based prenatal exclusion of harlequin ichthyosis
A Novel Mutation and Large Size Polymorphism Affecting the V2 Domain of Keratin 1 in an African-American Family with Severe, Diffuse Palmoplantar Keratoderma.
Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell.
First systematic experience of preimplantation genetic diagnosis for de-novo mutations  Svetlana Rechitsky, Ekaterina Pomerantseva, Tatiana Pakhalchuk,
Philippe Szankasi, Mohamed Jama, David W. Bahler 
Herlitz Junctional Epidermolysis Bullosa: Novel and Recurrent Mutations in the LAMB3 Gene and the Population Carrier Frequency  Aoi Nakano, Ellen Pfendner,
Combination of a Novel Frameshift Mutation (1929delCA) and a Recurrent Nonsense Mutation (W610X) of the LAMB3 Gene in a Japanese Patient with Herlitz.
Molly Yancovitz, Joanne Yoon, Maryann Mikhail, Weiming Gai, Richard L
A Child with Epidermolytic Ichthyosis from a Parent with Epidermolytic Nevus: Risk Evaluation of Transmission from Mosaic to Germline  Michihiro Kono,
Pedigree analysis through genetic hypothesis testing
A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote  Daniel F. Wallace, James S. Dooley, Ann P.
I. Silveira, I. Alonso, L. Guimarães, P. Mendonça, C. Santos, P
A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families  Wenhui L.
Inheritance of Mitochondrial DNA Recombinants in Double-Heteroplasmic Families: Potential Implications for Phylogenetic Analysis  Gábor Zsurka, Kevin.
Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism  Amy P. Hsu, BA, Kathryn J. Sowerwine, MD,
Epidermolysis Bullosa: Novel and De Novo Premature Termination Codon and Deletion Mutations in the Plectin Gene Predict Late-Onset Muscular Dystrophy 
Molecular cloning of pms916 salt hypersensitive T-DNA mutant.
Novel Homozygous and Compound Heterozygous COL17A1 Mutations Associated with Junctional Epidermolysis Bullosa  Michaela Floeth, Heike Schäcke, Nadja Hammami-Hauasli,
Survival of Male Patients with Incontinentia Pigmenti Carrying a Lethal Mutation Can Be Explained by Somatic Mosaicism or Klinefelter Syndrome    The.
Activation of a Cryptic Splice Site of PTEN and Loss of Heterozygosity in Benign Skin Lesions in Cowden Disease  Stephen J. Meltzer, Manfred Wolter  Journal.
Imprinting at the SMPD1 Locus: Implications for Acid Sphingomyelinase–Deficient Niemann-Pick Disease  Calogera M. Simonaro, Jae-Ho Park, Efrat Eliyahu,
Volume 2, Issue 2, Pages (August 1998)
Andrew Rowan, Ian Tomlinson  Journal of Investigative Dermatology 
A Homozygous Nonsense Mutation in Type XVII Collagen Gene (COL17A1) Uncovers an Alternatively Spliced mRNA Accounting for an Unusually Mild Form of Non-Herlitz.
Kimberly C. Sippel, Rebecca E. Fraioli, Gary D. Smith, Mary E
ATM Mutations and Phenotypes in Ataxia-Telangiectasia Families in the British Isles: Expression of Mutant ATM and the Risk of Leukemia, Lymphoma, and.
Germline Epigenetic Silencing of the Tumor Suppressor Gene PTPRJ in Early-Onset Familial Colorectal Cancer  Ramprasath Venkatachalam  Gastroenterology 
A Missense Mutation in the Zinc-Finger Domain of the Human Hairless Gene Underlies Congenital Atrichia in a Family of Irish Travellers  Wasim Ahmad, Alan.
Deletion of the Cytoplasmatic Domain of BP180/Collagen XVII Causes a Phenotype with Predominant Features of Epidermolysis Bullosa Simplex  Marcel Huber,
A Novel Point Mutation Affecting the Tyrosine Kinase Domain of the TRKA Gene in a Family with Congenital Insensitivity to Pain with Anhidrosis  Shinichi.
A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer  Zengliu Su, Dora Dias-Santagata,
Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas  Qiulu Pan, William Pao, Marc.
Volume 58, Issue 2, Pages (August 2000)
SLC7A9 mutations in all three cystinuria subtypes
A T G A G A T A A T T T A A G A B C Figure 1. Sequencing reveals mosaicism for point mutation. A, B. Sequencing analysis for.
Masahide Yazaki, Sandra A. Farrell, Merrill D. Benson 
Compound Heterozygosity for Novel Splice Site Mutations in the BPAG2/COL17A1 Gene Underlies Generalized Atrophic Benign Epidermolysis Bullosa  Leena Pulkkinen,
Wook Lew  Journal of Investigative Dermatology 
A T G A G A T A A T T T A A G A B C Figure 1. Sequencing reveals mosaicism for point mutation. (A) Sequence of tumor DNA (A)
Figure Novel compound heterozygous mutation in the COLQ gene causes congenital myasthenic syndrome Novel compound heterozygous mutation in the COLQ gene.
Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers  Ryoichi Onozato, MD,
A A G/A B G C Figure 1. Sequencing reveals mosaicism for point mutation. A. Sequencing shows a homozygous c.861 G>A mutation in the DNA from tumor of unilaterally.
A T G A G A T A A T T T A A G A B C Figure 1. Sequencing reveals mosaicism for point mutation. (A) Sequence of tumor DNA (A)
Marjolijn C. J. Jongmans, Eugene T. P
A T G A G A T A A T T T A A G A B C Figure 1. Sequencing reveals mosaicism for point mutation. (A) Sequence of tumor DNA (A)
Gonosomal Mosaicism for a Nonsense Mutation (R1947X) in the NF1 Gene in Segmental Neurofibromatosis Type 1  Claudia Consoli, Celia Moss, Stuart Green,
* * ↨ ↨ * * ↨ ↨ Figure 1: Early awareness of risk for retinoblastoma optimizes therapy and outcomes. This child was examined because his sibling (triplets)
A T G A G A T A A T T T A A G A B C Figure 1. Sequencing reveals mosaicism for point mutation. (A) Sequence of tumor DNA (A)
A T G A G A T A A T T T A A G A B C Figure 1. Sequencing reveals mosaicism for point mutation. (A) Sequence of tumor DNA (A)
Mutations in CHEK2 Associated with Prostate Cancer Risk
A B C D G G/A Figure 1. Sequencing reveals mosaicism for point mutation. A, B. Sequencing analysis for tumor DNA (A) and blood DNA (B) showed a homozygous.
Is Screening of the Candidate Gene Necessary in Unrelated Partners of Members of Families with Herlitz Junctional Epidermolysis Bullosa?  Alfred Klausegger,
Roland Kruse, Sven Cichon, Martina Anker, Axel M
Kit-Sing Au, Adelaide A. Hebert, E. Steve Roach, Hope Northrup 
Exon Skipping in IVD RNA Processing in Isovaleric Acidemia Caused by Point Mutations in the Coding Region of the IVD Gene  Jerry Vockley, Peter K. Rogan,
Novel Mutations in the LAMB3 Gene Shared by Two Japanese Unrelated Families with Herlitz Junctional Epidermolysis Bullosa, and Their Application for Prenatal.
Identification of Novel pro-α2(IX) Collagen Gene Mutations in Two Families with Distinctive Oligo-Epiphyseal Forms of Multiple Epiphyseal Dysplasia  Paul.
Presentation transcript:

A B C D G G/A Figure 1. Sequencing reveals mosaicism for point mutation. A. Sequencing shows a homozygous c.862 G>A mutation in the DNA from tumor of unilaterally affected proband (Family 1). B. the mutation was found in 15-20% of the proband’s leukocyte DNA as a small A peak present in the same position as the wild type G peak (green arrow). C, D. No mutation was observed in the DNA isolated from the mother or father’s blood.

C A Normal blood Bilateral blood Bilateral blood T G A C Normal blood A T C G B D Normal blood Bilateral tumor Heterozygous 2 bp  T G R C V M A K W A T C G Figure 2. QM-PCR detected mosiac deletions in blood of bilaterally affected probands: A. QM PCR reproducibly showed a subtle shoulder on the exon 23 peak (arrow) in the blood of bilaterally affected proband (Family 2), compared to exon 23 peak of a normal control and other normal exons 19 and 24 in both the normal control blood and bilaterally affected blood. B. Sequence showed a heterozygous 2 base pair deletion in the tumor (c2478delTC) (closed circles, normal sequence; open circles, mutant sequence; deleted bases below mutant; automatic reading detects the heterozygous mutant) and a low level of the same deletion in the blood of the bilaterally affected proband (automatic reading fails to detect the mosaic deletion). C. QM PCR showed a small peak preceding exon 10 peak in the blood from a bilaterally affected proband (Family 3), compared to normal exon 10 peak from a control blood and other normal peaks from both the proband and the normal control. B. Sequence showed a small population of DNA with 2 base pairs deleted (deletion site not shown). (??not detected? In an intron??) Bilateral blood Mosaic 2 bp  T G A C Bilateral blood Mosaic 2 bp 

Bilateral tumor 0 copies exon 3 2 copies other exons Bilateral blood 1.5 copies exon 3 Normal blood E Figure 2. QM-PCR detected mosiac deletions in blood of bilaterally affected probands: E. QM-PCR showed only background PCR product for exon 3 in retinoblastoma tumor of the proband in family 4, indicating homozygosity for the deletion. In comparison to the 2 copies of exon 3 in normal blood control, blood of the proband showed 1.5 copies of exon 3, suggesting mosaicism for the exon 3 deletion.

A C B Internal control R255X Blood % mutant DNA 100 10 2 N B S N Neg Internal control R255X Blood Sperm C G A T B Figure 3. Suspicion of mosaicism raised on sequence, confirmed by ASPCR. Unilateral, non-familial retinoblastoma had conventionally a 15% risk of germline RB1 mutation, with 7% risk of transmission to offspring. The half-blackened square represents the unilaterally affected individual. Sequence suggested a mosaic mutation in blood, indicated by the arrow indicating a low level of mutation; no tumor was available to confirm the mutation. ASPCR for the nonsense mutation R255X showed the proportion of mutant DNA in the proband’s blood to be about 5%, or the proportion of mutant leukocytes to be about 10%. Risk of transmission to offspring is reduced to about 5%. B, C. Sequence and ASPCR on sperm DNA showed no detectable signal (less than 1%), in comparison to blood DNA. Risk of transmission to offspring is reduced to less than 1%. N, normal (R255wt) control DNA; Neg, negative control (water); % mutant DNA included 100% (homozygous R255X tumor control), 10% and 2% mixtures of homozygous tumor to wild type DNA; B, proband blood DNA; S, proband sperm DNA. Mellone’s comments: Proband is not a true mosaic? (mosaic only in somatic cells or is he really a true germline (mosaic in all areas of body) mosaic such that mosaicism occurs in ,1% of germ cells; since level of detection is , 2%) BG: yes true mosaic, who said had to affect every tissue? ONLY SAY: NO EVIDENCE OF MUTATION IN SPERM; THEREFORE RISK OF TRANSMISSION TO OFFSPRING LESS THAT 1%. Still don’t understand why add normal DNA at a fixed concentration, why not amplify something within mutant DNA as an internal control? DON’T KNOW WHAT YOU MEAN Why is it necessary to show that it is at a constant amount, when that amount is actually fixed by you? WHEN THE REACTION IS SET UP TRY TO COVER THE RANGE; THEN THE PATIENT SAMPLE HAS A VALID COMPARATOR TO EXTIMATE THE % MOSAICISM. What is the purpose in showing that normal DNA is constant in each but that only the amount of mutant DNA is different (dilutions)? Is the purpose of the internal control strictly to show that DNA is present in a consistent amount in each lane? YES (2 reasons: 1. to make sure that DNA is present and it amplifies under their conditions and 2. to mimic the in vivo model)

A B C ??? C A T G C Y I-1 I-2 II-1 II-2 II-3 Blood I-2 Blood II-1 Amniocytes fetus II-2 Cord blood newborn II-2 Amniocytes fetus II-3 Figure 4. Suspicious by sequencing and confirmed by ASPCR A. Pedigree of family with unilaterally affected mother (I-2) and two children (II-2, II-3) at risk for familial retinoblastoma. Black and half-black circles represent bilaterally and unilaterally affected individuals respectively; black dot indicates presence of the constitutional mutation. B. Sequence showed the heterozygous RB1 mutant allele (R445X) in the bilaterally affected daughter’s blood (II-1), but not in the blood of the mother (I-2) or her second child (II-2). Her third child (II-3) was shown prenatally to carry the same mutation the affected child (II-1). C. ASPCR analysis for the nonsense mutation R455X on blood samples of unilaterally affected mother (I-2) and her bilaterally affected daughter (II-1). Normal (R455wt) control DNA sample, labeled N, Neg, negative control????. The proportion of mutant leukocytes in the mother’s blood was approximately 20%. N 1/10 1/100 1/20 Neg II-1 1/1 I-2 R455X R455wt ??? C

Table 1: Frequency of Mosaicism All mosaic cases to be included.

Total Tested 320 Mutation Found 294 92% No Mutation Found 26 8% AS-PCR Extrapolation from AS-PCR-detected mosaicsm indicates that the majority of “missing” RB1 mutations are mosaic. (Other mutation detection technologies do not detect mosaicism.) Total Tested 320 Mutation Found 294 92% No Mutation Found 26 8% AS-PCR 56 19% non AS-PCR 238 81% Mosaic 6 11% Not Mosaic 50 89% 26 11% 238 89% Table 2: All Mosaic cases Update this table Extrapolated Figure 4